GLAXOSMITHKLINE, S.A. secures contract for Vaccines - Acquisition of Tetravalent vaccine against Diphtheria-Tetanus-Acellular Pertussis, Injectable Poliomyelitis (DTPa-VPI), destined for the CAE vaccination program

Spain, Jan. 12 -- Spain based GLAXOSMITHKLINE, S.A. has secured contract from Organo Administrativo de Recursos Contractuales for Vaccines - Acquisition of Tetravalent vaccine against Diphtheria-Tetanus-Acellular Pertussis, Injectable Poliomyelitis (DTPa-VPI), destined for the CAE vaccination program. The value of the contract is worth 1530 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....